Solifenacin Succinate 5 MG

DRUG4 trials

Sponsors

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Beni-Suef University, Chang Gung Memorial Hospital, Bir Hospital

Conditions

Detrusor OveractivityOveractive BladderOveractive Bladder SyndromeUreteral Stent-Related SymptomVoiding Disorders

Phase 3

Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms

RecruitingNCT06803030

Bir HospitalUreteral Stent-Related Symptom

Start: 2025-08-30End: 2026-12-31Target: 189Updated: 2025-09-08

Phase 4

Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

CompletedNCT03558919

Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshOveractive Bladder

Start: 2017-01-01End: 2017-12-30Updated: 2018-06-19

Unknown Phase

Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

CompletedNCT04064619

Beni-Suef UniversityVoiding Disorders

Start: 2018-01-01End: 2019-08-02Updated: 2019-08-22

Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker

Chang Gung Memorial HospitalDetrusor Overactivity, Overactive Bladder Syndrome

Start: 2021-03-01End: 2022-12-31Target: 400Updated: 2021-01-27